<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141362">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02059083</url>
  </required_header>
  <id_info>
    <org_study_id>13-0412</org_study_id>
    <nct_id>NCT02059083</nct_id>
  </id_info>
  <brief_title>Biofeedback for Adolescent Cannabis Use Disorder</brief_title>
  <official_title>Biofeedback for Adolescent Cannabis Use Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Denver Health and Hospital Authority</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Denver Health and Hospital Authority</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this study are: 1) to estimate the effect size of HRV biofeedback for stress in
      adolescents undergoing cognitive behavioral therapy (CBT) for cannabis use disorder (primary
      outcome: Perceived Stress Scale) and 2) to estimate the effect size of HRV biofeedback for
      cannabis use in adolescents undergoing CBT for cannabis use disorder (primary outcome:
      number of days used cannabis in the past 30 days).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Perceived Stress Scale</measure>
    <time_frame>baseline and 16 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the number of days used marijuana in the past 28 days</measure>
    <time_frame>baseline and 16 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Adolescent Cannabis Use Disorder</condition>
  <arm_group>
    <arm_group_label>Cognitive behavioral therapy (CBT) alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Cognitive behavioral therapy plus HRV biofeedback</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Heart rate variability biofeedback</intervention_name>
    <arm_group_label>Cognitive behavioral therapy plus HRV biofeedback</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT</intervention_name>
    <arm_group_label>Cognitive behavioral therapy (CBT) alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  be between the ages of 13 and 19 years, with a parent or legal guardian available to
             complete parental assessments, if the participant is a minor

          -  meet Diagnostic and Statistical Manual of Mental Disorders, 5th edition, (DSM-V)
             criteria for cannabis use disorder by clinical interview;

          -  be medically healthy;

          -  be willing to participate in the study intervention and assessments;

          -  plan to live locally for at least 4 months;

          -  be able to read English well enough to complete study questionnaires;

          -  have self-reported cannabis use in the past 28 days;

          -  have a Perceived Stress Scale score &gt; 20.

        Exclusion Criteria:

          -  current or past psychosis;

          -  bipolar I or II disorder;

          -  the need to take psychotropic medications at any time during the study;

          -  pregnancy;

          -  psychiatric or substance use disorder that cannot be managed with outpatient care
             (e.g. alcohol withdrawal, severe major depressive disorder, significant suicidal
             ideation); and

          -  medications known to affect HRV (e.g. albuterol, pseudoephedrine, beta adrenergic
             blockers).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Thurstone, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Denver Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Thurstone, M.D.</last_name>
    <phone>303-602-1896</phone>
    <email>christian.thurstone@dhha.org</email>
  </overall_contact>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 7, 2014</lastchanged_date>
  <firstreceived_date>February 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adolescent</keyword>
  <keyword>cannabis</keyword>
  <keyword>biofeedback</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
